BERKELEY, Calif., Oct. 1 /PRNewswire/ -- Berkeley BioSciences, Inc., co-founded by Dr. Leonard Bjeldanes, Professor and former Chairman of the Department of Nutritional Sciences at UC Berkeley and Dr. Gary Firestone, Director of the National Institutes of Health Cancer Research Program at UC Berkeley, announces the launch of ActivaMune -- an advanced immune support formula exclusively licensed from UC Berkeley. (http://www.ActivaMune.com/).
ActivaMune is based on a breakthrough discovery by Dr. Bjeldanes and Dr. Firestone regarding the potent immune activating properties of Diindolylmethane (DIM), a naturally occurring compound found in Brassica vegetables (broccoli, cauliflower, cabbage, kale, Brussels sprouts). This compound has been shown to modulate key immune enhancing cytokines in addition to inducing Interferon-Gamma Receptors on diseased cells, selectively marking them for destruction by the immune system with no effect on healthy cells.
DIM, at dietary supplemental dosages, is currently used as a treatment for Recurring Respiratory Papillomatosis tumors (caused by the Human Papillomavirus) and is in Phase III clinical trials for Cervical Dysplasia (also caused by HPV). Until this recent discovery regarding its potent immune modulating properties, the efficacy of this compound against these conditions was not clearly understood. As a result of this discovery, Diindolylmethane is currently under investigation as a natural therapeutic for most viral infections (including HPV, Influenza, Hepatitis & HIV) and antibiotic resistant bacteria. As DIM has both immune modulating properties that fight cancer, as well as direct anti-cancer properties (such as apoptosis promotion) it is also currently in clinical trials sponsored by the National Cancer Institute as a natural therapeutic for various forms of cancer.
Epidemiological studies have indicated that people who regularly
|SOURCE Berkeley BioSciences, Inc.|
Copyright©2007 PR Newswire.
All rights reserved